Market Access Matters

Adrian Harrington, Senior Director Value and Access at Biogen, joins the podcast to discuss market access excellence – what it means to him, and the critical role visual communication is playing for market access leaders. Adrian also shares his views on what’s next for the market access function, detailing why leaders must embrace opportunities to demonstrate the value of market access and tell the story of their team’s success. Strong communication strategies are clearly important to Adrian and it’s a theme that sits at the heart of this episode. The opinions shared in this episode are Adrian's own views and not representative of the company he is working for.

In this special episode, Louise teams up with colleagues Thomas Gilboy and Shravani Madishetti from Access Infinity to explore the transformative impact of digital on market access. Shravani, APAC Pricing and Market Access Lead, highlights the efficiency and accuracy achieved through digital tools while Tom, Product Owner for Nuro, emphasises the importance of maximising the effectiveness of digital tools. Together, they offer valuable insights and practical guidance for navigating this evolving landscape.

In the third episode of series 2, Louise interviews Khalid Mirza, Senior Director, Global Market Access & Pricing, Oncology at Daiichi Sankyo. They discuss Khalid's journey into market access, and how, for him, it's evolved into an exciting career path where science meets commercial. They also touch on the key themes shaping the future of market access, where Khalid's positive energy and passion for the function shines. The opinions shared in this episode are Khalid's own views and not representative of the company he is working for.

In this episode Louise teams up with Access Infinity Partner, Nick Proctor. Nick has been a consultant in the biopharmaceutical industry for over twenty years and shares his views on the hot topics and trends which he feels will have the biggest impact on market access in the coming years, also offering his insights on the themes which are 'hype'. Throughout his career Nick has also been responsible for training, coaching and mentoring others in global market access and pricing, and talks to Louise about his passion for empowering aspiring market access leaders on their own professional growth journeys.

Welcome back to the Market Access Matters podcast! In the first episode of series 2, Louise interviews David McConkey, Virology and Oncology Global Value and Access Director at Gilead Services. Having started his career in consulting and then working across global and country roles, David has a breadth of experience in market access. In this discussion he shares his experiences of taking on new challenges, leading teams into new territories and what he's learnt along the way. The opinions shared in this episode are David's own views and not those of the company he is working for.

In this episode we’re joined by Katie Gardner, who is Head of Global Market Access Excellence at Astellas. We hear Katie’s insights on the changing landscape of market access and what it demands from teams in terms of agility and innovation. She talks about how digital technology can empower teams to evolve with the ever-changing demands of the market and what her team are doing to drive market access excellence. Katie is passionate about building high performing teams and discusses the role of mindset within this. It’s a fascinating discussion with valuable insights and advice shared, especially for market access professionals striving for professional growth. The opinions shared in this podcast are Katie's own views.

In this episode we're joined by Pfizer's Director Global Market Access for Medical Dermatology, Séverine Baquart. Séverine's career spans over twenty years at Pfizer, where she's seen significant change including the separation of the market access and pricing function from regulatory affairs. In this conversation, Séverine shares what she loves most about market access, the innovations she's seen and her aspirations for the future of market access on a global scale. The opinions shared in this podcast are Séverine's own views.

Shravani Madishetti is Access Infinity's APAC Pricing and Market Access Lead. Before taking on this role, Shravani specialised in pricing and market access for Novartis, where she was based for over seven years. She now leads a team that supports data functionality for our digital solutions, Access Hub and Nuro. In this episode, we discuss Shravani's unique perspective on market access and why it provides a rewarding career path.

In this episode we're joined by Paula Albuquerque, who is Director Global Market Access Immuno - Rheumatology at UCB. Paula has a comprehensive global background within the healthcare, pharmaceutical, biotech and management consulting sectors and has a strong focus on how to translate science into commercial value propositions. Paula discusses her purpose: bringing to market and launching new medicines in the way that considers the needs and realities of the patients and health systems. She also reflects on key takeaways from the global launches she's been involved in, and shares what she's doing to prepare for the future of market access. The opinions shared in this podcast are Paula's own views.

In this episode, Louise interviews Access Infinity's Client Success Manager Cloë Carey. Cloë and her surrounding team are pioneering digital transformation in pharma and specifically, market access. They discuss Cloë's natural interest in science when she was young and how this influenced her career path. Cloë also shares what it is about market access that keeps her engaged and excited as well as what she's learnt along the way.

In this episode Louise is joined by Ana Plata, Global Pricing Head - BioPharmaceuticals at AstraZeneca. Ana specialises in strategic pricing and market access to support pharmaceutical life cycles and discusses her career journey to date, which has included working across both industry and consulting. Ana has a clear passion for developing and leading teams. She shares her views on the importance of supporting people to grow, the power of connecting with peers and the value of mentors and coaching to support career journeys and growth, which by her own admission, is rarely a linear path.

In this episode, Louise is joined by Clare Marley, Disease Area Head Immunology, Global Payer Strategy at GSK. Clare has been at GSK for nearly a decade where she's focused heavily on global market access and payer strategy. As we hear in this episode, Clare has spent much of her career in market access and has seen the function evolve from an entirely new area to what it is today. She discusses the changes she's seen and shares her views on what's on the horizon for global market access teams as the function continues to evolve.

For our first ever podcast recording, Louise is joined by Access Infinity Associate Director and colleague, Isabel Rubio. Isabel joined the team last year and brings with her a wealth of knowledge and experience having lived and worked in many different countries. We talk about this more in this episode, where Isabel shares her positive experiences of working in market access and the benefits of taking risks.